By A Mystery Man Writer
Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.
Global Service Providers Guide 2022 by Enhesa Product - Issuu
Novartis to eliminate up to 8000 jobs under cost-cutting plan
San Francisco - TDV Global Inc.
Marie-Claude Léonard appointed interim CEO of STM
NOVARTIS AG Form 20-F Filed 2021-01-26
Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group - eClinicalMedicine
Michael Meegan on LinkedIn: Novartis cuts top commercial title
Novartis names new board member after international boss steps down
Novartis: Half of 1,400 Swiss Job Cuts are Leadership Positions
Novartis to cut up to 8,000 jobs globally
UPDATED: Novartis CEO Vas Narasimhan restructures the pharma giant, cutting costs $1B+, ousting top execs and signaling layoffs ahead - ECHEMI
Vas Narasimhan on LinkedIn: Of all the achievements Novartis shared yesterday to mark our Annual…
Interview – Open discussion between Susanne Schaffert, Novartis and Cary Adams, UICC
Biomanufacturing World Summit